QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

WGS

QT68GeneDx Holdings Corp.
NASDAQ·Healthcare·Medical - Healthcare Information Services·USA
Latest market price
59.01
+2.59+4.59%
OverviewShort InterestFilings
WGSQT68GeneDx Holdings Corp.·NASDAQ
OverviewShort InterestFilings
59.01+4.59%
TA
Loading chart...
Screen all →
GEHC+0.72%$61.59VEEV-1.00%$153.30BTSG+2.82%$66.25TEM+4.20%$50.84HQY-1.30%$85.21HNGE+3.55%$69.42TXG+8.19%$34.76DOCS+0.05%$20.46
Snapshot
Index-P/E-EPS (ttm)-2.66
Insider Own-
Shs Outstand29.69M
Perf Week-3.25%
Market Cap1.67BForward P/E47.93EPS next Y1.23Insider Trans11.73%Shs Float-Perf Month40.07%
Enterprise Value1.75BPEG-EPS next Q-0.19Inst Own-Short Float-Perf Quarter-19.16%
Income-78724857.00P/S3.78EPS this Y97.31%Inst Trans-Short Ratio-Perf Half Y-58.36%
Sales442.67MP/B6.51EPS next Y1823.74%ROA-15.37%Short Interest-Perf YTD-54.63%
Book/sh8.56P/C-EPS next 5Y-ROE-27.50%52W High170.85 -65.46%Perf Year-7.85%
Cash/sh5.76P/FCF-EPS past 3/5Y-ROIC-8.07%52W Low32.21 83.20%Perf 3Y-
Dividend Est.-EV/EBITDA-36.07Sales past 3/5Y22.12% 19.05%Gross Margin68.35%Volatility4.65% 5.10%Perf 5Y-
Dividend TTM-EV/Sales3.95EPS Y/Y TTM143.81%Oper. Margin-7.72%ATR (14)4.41Perf 10Y-
Dividend Ex-Date-Quick Ratio2.95Sales Y/Y TTM45.25%Profit Margin-17.58%RSI (14)56.78Recom2.00
Dividend Gr. 3/5Y-Current Ratio3.09EPS Q/Q-200.00%SMA209.10%Beta1.81Target Price96.43
Payout0.00%Debt/Eq0.66Sales Q/Q17.24%SMA507.70%Rel Volume0.46Prev Close56.42
Employees1,000LT Debt/Eq0.46EarningsAug 04SMA200-40.65%Avg Volume1.42MPrice59.01
IPO DateNov 04, 2020Option/ShortYes / YesEPS/Sales Surpr.-366.67% -8.93%Net Debt/EBITDA-1.53Volume658,565Change4.59%
Analyst Ratings
DateActionAnalystRatingTarget
May-05-26ReiteratedCraig-HallumBuy$153 → $85
May-05-26ReiteratedGuggenheimBuy$170 → $70
May-05-26ReiteratedBTIGBuy$170 → $90
May-05-26ReiteratedCanaccord GenuityBuy$100 → $75
May-05-26ReiteratedWells FargoOverweight$155 → $75
Apr-20-26ReiteratedCanaccord GenuityBuy$170 → $100
Feb-24-26ReiteratedBTIGBuy$200 → $170
Feb-24-26ReiteratedPiper SandlerOverweight$120 → $130
Feb-23-26ReiteratedJefferiesBuy$180 → $150
Feb-09-26UpgradeWells FargoEqual Weight → Overweight
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue443428305
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A140129111
Gross Profit303298194
Selling, General and Administrative Excl. Other262239168
Research and Development797246
Other Operating Expense-404
Operating Income-34-12-23
Interest Expense433
Unusual Expense
———
Non-Operating Income (Expense)42726
Net Income Before Taxes-76-21-53
Income Taxes000
Consolidated Net Income-78-21-52
Net Income From Continuing Operations-78-21-52
Net Income-78-21-52
EPS (Recurring)-2.66-0.73-1.94
EPS (Basic, Before Extraordinaries)-2.66-0.73-1.94
EPS (Diluted)-2.66-0.73-1.94
EBITDA-487-28
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio3.868.20—
Gross Margin68.4069.6363.61
Operating Margin-7.67-2.80-7.54
Net Margin-17.61-4.91-17.05
Shares Outstanding292727
Market Capitalization1,7113,512—
Operating Lease Expense
———
Insider Trading Volume
$62.52$58.74$54.97$51.19$47.41● Close Price0.00M20.51M41.02M61.52M82.03MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Feeley KevinCHIEF FINANCIAL OFFICERJun 09 '26Sale53.771,26668,07336,486Jun 11 12:00 AM
Feeley KevinCHIEF FINANCIAL OFFICERJun 09 '26Option Exercise0.004,924037,752Jun 11 12:00 AM
Stueland KatherineCHIEF EXECUTIVE OFFICERJun 09 '26Option Exercise0.0013,092099,762Jun 11 12:00 AM
Stueland KatherineCHIEF EXECUTIVE OFFICERJun 09 '26Sale53.773,639195,66996,123Jun 11 12:00 AM
Casdin Capital, LLCdirector, 10 percent owner:Jun 05 '26Buy52.8650,0002,642,8303,707,164Jun 08 12:00 AM
Casdin Capital, LLCdirector, 10 percent owner:Jun 04 '26Buy56.44150,0008,466,7353,657,164Jun 08 12:00 AM
Casdin Capital, LLCdirector, 10 percent owner:May 20 '26Buy43.81140,0006,132,8543,507,164May 20 12:00 AM
Casdin Capital, LLCdirector, 10 percent owner:May 19 '26Buy42.60185,0007,880,3343,367,164May 20 12:00 AM
Casdin Capital, LLCdirector, 10 percent owner:May 18 '26Buy42.55175,0007,446,5473,182,164May 20 12:00 AM
Meister Keith A.director, 10 percent owner:May 15 '26Buy38.9146,2731,800,5714,784,570May 15 12:00 AM
Meister Keith A.director, 10 percent owner:May 14 '26Buy39.39140,0005,514,7914,738,297May 15 12:00 AM
Meister Keith A.director, 10 percent owner:May 13 '26Buy39.09165,0006,449,9844,598,297May 15 12:00 AM
Casdin Capital, LLCdirector, 10 percent owner:May 11 '26Buy0.0050,0000850,000May 11 12:00 AM
Meister Keith A.director, 10 percent owner:May 11 '26Buy39.29500,00019,642,7894,433,297May 11 12:00 AM
Casdin Capital, LLCdirector, 10 percent owner:May 08 '26Buy0.00300,0000800,000May 11 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR